We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03967223
Brief Title: Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors (IGNYTE-ESO)
First Submitted : May 10, 2019
First Submitted that Met QC Criteria : May 28, 2019
First Posted : May 30, 2019
Last Update Submitted that Met QC Criteria : October 28, 2022
Last Update Posted : October 31, 2022